Cancer

Proteomic data are a uniquely valuable resource for drug response prediction and biomarker discovery because most drugs interact …

Proteomic data can reveal novel associations between genotype and phenotype, beyond what is apparent from genomics or transcriptomics alone. However, a lack of large proteomic datasets across a range of cancer types has limited our understanding of proteome network organisation and regulation.

Cancer arises from successive rounds of mutations which generate tumor cells with different genomic variation i.e. clones. For drug …